<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Possible Interactions of Drugs Used for COVID-19 Therapy With Cardiac Drugs</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Treatment</th>
    <th>Select Drug-Drug Interactions
     <xref rid="tbl1fnlowast" ref-type="table-fn">∗</xref>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Azithromycin</td>
    <td>↓ in HR, ↑ PR interval, ↑↑ in QTc interval with very low risk of TdP.
     <break/>AAD drug interactions:
     <list list-type="simple" id="ulist0015">
      <list-item id="u0030">
       <p id="p0210">Severe: amiodarone, disopyramide, dofetilide, flecainide, sotalol, propafenone</p>
      </list-item>
      <list-item id="u0035">
       <p id="p0215">Moderate: BBs, digoxin</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td>(Hydroxy) chloroquine</td>
    <td>↓ in HR, ↑ PR interval, ↑↑ in QTc interval with very low risk of TdP.
     <break/>AAD drug interactions:
     <list list-type="simple" id="ulist0020">
      <list-item id="u0040">
       <p id="p0220">Severe: amiodarone, flecainide, mexiletine, sotalol, dofetilide</p>
      </list-item>
      <list-item id="u0045">
       <p id="p0225">Moderate: disopyramide, propafenone, quinidine, digoxin</p>
      </list-item>
      <list-item id="u0050">
       <p id="p0230">Mild: metoprolol, nebivolol, propranolol, timolol, verapamil</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td>Lopinavir/ritonavir</td>
    <td>↑ PR interval, ↑↑ in QTc interval with low risk of TdP.
     <break/>AAD interactions:
     <list list-type="simple" id="ulist0025">
      <list-item id="u0055">
       <p id="p0235">Severe: amiodarone, dronedarone, disopyramide, dofetilide, flecainide, sotalol</p>
      </list-item>
      <list-item id="u0060">
       <p id="p0240">Moderate: lidocaine, mexiletine, propafenone, quinidine, digoxin, BBs, CCBs</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Unknown</td>
   </tr>
   <tr>
    <td>Fingolimod/siponimod</td>
    <td>↓↓↓in HR, ↑↑ in PR interval, ↑ in QTc prolongation with unknown risk of TdP.
     <break/>AAD interactions:
     <list list-type="simple" id="ulist0030">
      <list-item id="u0065">
       <p id="p0245">Moderate: BBs, CCBs, ivabradine, amiodarone, flecainide, propafenone</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td>Ribavirin</td>
    <td>Unknown</td>
   </tr>
   <tr>
    <td>Tocilizumab</td>
    <td>No ECG changes described
     <break/>AAD interactions:
     <list list-type="simple" id="ulist0035">
      <list-item id="u0070">
       <p id="p0250">Mild: amiodarone, quinidine</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td>Methylprednisolone</td>
    <td>Unknown</td>
   </tr>
   <tr>
    <td>Interferon alfa-1</td>
    <td>Unknown</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>↑/↓ = mild increase/decrease; ↑↑/↓↓ = moderate increase/decrease; ↑↑↑/↓↓↓ = severe increase/decrease; AAD = antiarrhythmic drug; BB = beta-blocker; CCB = calcium-channel blocker; COVID-19 = coronavirus disease-2019; ECG = electrocardiography; HR = heart rate; TdP = torsades de pointes</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnlowast">
   <label>∗</label>
   <p id="ntpara0015">Severe: drugs should not be administered; moderate: potential interaction, need dose adjustments/close monitoring; mild: weak intensity interaction, need for dose adjustments/close monitoring is unlikely to be required.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
